Evidence-Based Deep Dive

Navi Medical Technologies has raised A$6.8 million to support the US commercialization of its Neonav® vascular access technology following FDA 510(k) clearance and the start of clinical evaluations at two leading US children's hospitals.
Led by KP Rx, with participation from Innovation Victoria and P

REEV has initiated a pivotal clinical study evaluating DREEVEN, an intelligent robotic knee-ankle-foot orthosis designed to improve mobility and independence for stroke survivors with chronic gait impairment.
The study, conducted with clinical partners including Encompass Health, Whittier Rehabilitat

Aurenar has raised $5.7 million in an oversubscribed seed round to accelerate development of its V-Link noninvasive neuromodulation system, designed to reduce cerebral vasospasm in adults with aneurysmal subarachnoid hemorrhage (aSAH).
The funding, co-led by the Go-Red for Women Venture Fund from Ame

Aqua Medical has treated the first U.S. patient in its FDA investigational device exemption (IDE) trial evaluating its minimally invasive procedure for type 2 diabetes.
The company’s proximal intestinal mucosal ablation (PIMA) procedure uses radiofrequency vapor ablation through a standard endoscope

Dopl Technologies has raised $6.3 million in seed funding to accelerate development of its remote robotic ultrasound platform designed to expand access to diagnostic imaging.
The Washington-based startup is developing a telerobotic system that enables sonographers to perform ultrasound exams remotely

Xeltis has secured an additional €20.5 million in funding, led by Horizon 3 Healthcare, to advance its aXess™ vascular access implant toward FDA approval and US commercialization.
The financing builds on the €50 million raised in 2025 and will support completion of the ongoing US pivotal trial, FDA s

MIT spinout Magnendo has raised $18M in a Series A round led by Penumbra to accelerate development of its magnetic robotic navigation platform for neuro-endovascular procedures.
The technology combines magnetically steerable guidewires, robotic control, advanced imaging and AI-powered navigation soft

Momentis Surgical has received FDA 510(k) clearance for the multiport configuration of its Anovo® Surgical System, making it the first robotic platform designed to support natural orifice, single-port, and multiport surgical approaches on a single system.
The expanded clearance increases the flexibil

Wellumio has raised $9.75 million in an oversubscribed pre-Series A financing round to accelerate development of its portable, AI-powered MRI system for rapid stroke diagnosis at the point of care.
The funding, backed by new investors Bioshore Ventures and Jumpspace Ventures alongside existing invest